Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk

Patrick Mathieu1, Marie-Chloé Boulanger, Jean-Pierre Després

  • 1Institut de Cardiologie et de Pneumologie de Québec/Quebec Heart and Lung Institute, 2725 Chemin Ste-Foy, Québec, QC, G1V-4G5, Canada, patrick.mathieu@chg.ulaval.ca.

Insights

Ectopic visceral fat accumulation is increasingly linked to cardiovascular diseases (CVDs) beyond coronary artery disease. Understanding these molecular links is crucial for managing residual risk and improving patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Medical Imaging

Background:

  • Cardiovascular diseases (CVDs) remain a primary cause of global mortality.
  • Despite reduced smoking rates and focus on classical risk factors, a significant residual risk for CVDs persists.
  • Ectopic visceral fat accumulation is recognized as a key contributor to metabolic dysfunction and cardiovascular disorders.

Purpose of the Study:

  • To review the molecular mechanisms connecting ectopic fat accumulation to the development of various CVDs.
  • To explore the translational relevance of these molecular processes in clinical observations.
  • To highlight emerging evidence on ectopic fat's role in conditions beyond coronary artery disease.

Main Methods:

  • Comprehensive literature review of imaging studies and molecular research.
  • Analysis of data spanning over two decades.
  • Translational approach linking pathobiology to clinical observations.

Main Results:

  • Ectopic visceral fat is strongly associated with metabolic dysfunctions contributing to CVDs.
  • Established link between visceral fat and coronary artery disease (CAD).
  • Emerging evidence implicates ectopic fat in calcific aortic valve disease (CAVD), atrial fibrillation, and left ventricular dysfunction.

Conclusions:

  • Ectopic fat accumulation is a critical, yet often overlooked, factor in the pathogenesis of diverse cardiovascular diseases.
  • Understanding the molecular pathways is essential for developing novel therapeutic strategies targeting residual cardiovascular risk.
  • A translational approach integrating molecular insights with clinical data is vital for advancing cardiovascular medicine.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
930
Hypodermis01:02

Hypodermis

The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
7.6K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
766
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
806